Department of Dermatology, University of California San Francisco, San Francisco, CA, USA.
Drug Dev Ind Pharm. 2013 Sep;39(9):1401-7. doi: 10.3109/03639045.2012.704041. Epub 2012 Aug 9.
This study determined the onychopharmacokinetics, nail absorption, distribution, and penetration of [¹⁴C]-terbinafine HCl in a new topical formulation into/through the human finger nail using the in vitro finite dose model. This study determined the penetration rate of terbinafine HCl from multiple doses of topical formulation applied daily for 14 days. Results showed that the total dose recovery (mass balance) was almost 100%. The concentration of terbinafine HCl in the deeper nail plate (ventral/intermediate layers) and the cotton-pad nail bed samples after the 14-day treatment were 613 ± 145 and (±S.D.) and 27 ± 1.2 µg/cm³ (or 1.9 ± 0.6 µg/cm³ daily) on average, respectively. In comparison with nail concentration data from the literature for other topical terbinatine formulations, our results show that higher amounts of terbinafine HCl reached the deep nail plate and/or the nail bed after a 14-day topical treatment with this topical formulation in vitro.
本研究采用体外有限剂量模型,测定了[¹⁴C]-盐酸特比萘芬新局部制剂进入/穿过人手指甲的药物动力学、指甲吸收、分布和渗透情况。本研究测定了特比萘芬盐酸盐从每日应用多次局部制剂 14 天的渗透速率。结果表明,总剂量回收率(质量平衡)几乎为 100%。在 14 天治疗后,深层指甲板(腹侧/中间层)和棉垫指甲床样本中的特比萘芬盐酸盐浓度分别为 613±145和(±标准差)和 27±1.2 µg/cm³(或平均每天 1.9±0.6 µg/cm³)。与其他局部特比萘芬制剂的文献中指甲浓度数据相比,我们的结果表明,与其他局部特比萘芬制剂相比,这种局部制剂在体外进行 14 天局部治疗后,有更多的特比萘芬 HCl 到达深层指甲板和/或指甲床。